Current Environment:

David Shulman | Education

Medical School

Harvard Medical School

2013, Boston, MA



Boston Combined Residency Program (BCRP)

Boston, MA


Boston Children's Hospital/Dana-Farber Cancer Institute

Boston, MA

David Shulman | Professional History

Dr. David Shulman studies novel therapies and biomarkers for advanced pediatric solid tumors within the Dana-Farber Experimental Therapeutics Program. In addition to early phase clinical trials, Dr. Shulman also studies circulating tumor DNA as a potential tool to improve the ways in which we treat patients with bone tumors,

David Shulman | Publications